<DOC>
	<DOCNO>NCT00060489</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety quetiapine treatment major depressive episode patient bipolar disorder .</brief_summary>
	<brief_title>Safety Efficacy Trial Use Quetiapine Fumarate ( SEROQUELÂ® ) Treatment Patients With Bipolar Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Written Informed Consent ; Bipolar disorder recent episode depress ; Outpatient status Patients current Axis I disorder bipolar disorder within 6 month screen ; Patients whose current episode depression exceed 12 month less 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Bipolar Depression</keyword>
</DOC>